Categories: News

GAC Accelerates European Market Plan, Partnering with Magna to Deepen Localized Cooperation

GRAZ, Austria, Nov. 21, 2025 /PRNewswire/ — Today, GAC and Magna announced a widespread cooperation program to accelerate electric mobility and expand EV collaboration in Europe. The collaboration underscores GAC’s regional commitment, extending technical cooperation, supply and sales, while highlighting Magna’s leadership in vehicle manufacturing. Localized and customized collaboration of GAC’s electric SUV AION V is now underway at Magna’s Graz facility.

- Advertisement -

“Europe is a vital market in GAC’s global development,” said Wei Haigang, President of GAC INTERNATIONAL. “Partnering with Magna enables us to bring locally assembled electric vehicles to European customers that reflect GAC’s values of smart technology, sustainability and craftsmanship.”

- Advertisement -

Roland Prettner, President of Magna Complete Vehicles, added: “This collaboration reflects the trust automakers place in Magna’s expertise. Our local resources and technical advantage could allow OEMs like GAC to realize localized development strategies efficiently and confidently.”

- Advertisement -

The AION V, which earned a five-star Euro NCAP rating, debuted in Finland, Poland and Portugal. GAC plans to expand into additional European markets through new partnerships, service and sales networks.

- Advertisement -

Magna’s Graz operation, known for operational excellence, is capable of producing internal combustion, hybrid and electric vehicles on shared lines. With 125 years of manufacturing experience, Magna has developed 40+ vehicle models and produced over 4 million vehicles worldwide.

- Advertisement -

Together, GAC and Magna are shaping the future of mobility by combining electrification, design and manufacturing expertise. It underscores both companies’ commitment to quality, reliability and sustainable mobility across Europe and beyond.

- Advertisement -

About Magna International

- Advertisement -

Magna is one of the world’s largest automotive suppliers and a trusted partner to automakers in the industry’s most critical markets—North America, Europe, and China. With a global team and footprint spanning 28 countries, we bring unmatched scale, trusted reliability, and proven execution. Backed by nearly seven decades of experience, we combine deep manufacturing expertise with innovative vehicle systems to deliver performance, safety and quality. 

- Advertisement -

For further information about Magna, please visit www.magna.com or follow us on social. 

- Advertisement -

About GAC Group

- Advertisement -

Founded in 1997 and headquartered in Guangzhou, GAC GOURP has been on the Fortune Global 500 for 13 consecutive years. With comprehensive R&D and manufacturing, and brands including GAC, AION and HYPTEC, GAC is dedicated to intelligent, high-quality, and sustainable mobility.

- Advertisement -

For further information about GAC Group, please visit: https://www.gacgroup.com/en-eu/ or follow us on social. 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2829515/GAC.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/gac-accelerates-european-market-plan-partnering-with-magna-to-deepen-localized-cooperation-302623028.html

- Advertisement -

Recent Posts

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

5 minutes ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

5 minutes ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

6 minutes ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

6 minutes ago